Supplementary Information for Nature Medicine

Supplementary Information for Daluiski et al., Orthopedics

Genes up or down-regulated in fracture non-unions (greater than 2-fold)
Gene Description / Gene Symbol / Average Fold Change
immunoglobulin lambda locus / IGL / 47.0
immunoglobulin lambda joining 3 / IGLJ3 / 40.9
immunoglobulin heavy constant mu / IGHM / 39.5
immunoglobulin heavy constant gamma 3 (G3m marker) / IGHG3 / 37.8
immunoglobulin kappa constant / IGKC / 37.6
EST, Moderately similar to S72664 Ig heavy chain V region precursor - human [H.sapiens] / 36.5
cartilage acidic protein 1 / CRTAC1 / 35.6
Immunoglobulin mu heavy chain variable region [Homo sapiens], mRNA sequence / 34.9
similar to bK246H3.1 (immunoglobulin lambda-like polypeptide 1, pre-B-cell specific) / LOC91316 / 34.0
EST, Moderately similar to S72664 Ig heavy chain V region precursor - human [H.sapiens] / 28.5
immunoglobulin lambda locus / IGL / 26.3
immunoglobulin heavy constant mu / IGHM / 23.6
cytokine receptor-like factor 1 / CRLF1 / 20.4
chemokine (C-X-C motif) ligand 13 (B-cell chemoattractant) / CXCL13 / 20.3
immunoglobulin heavy constant mu / IGHM / 18.4
Homo sapiens cDNA FLJ35259 fis, clone PROST2004251, mRNA sequence / 18.2
dentin matrix acidic phosphoprotein / DMP1 / 17.9
immunoglobulin kappa constant / IGKC / 17.5
immunoglobulin heavy constant mu / IGHM / 15.8
clusterin (complement lysis inhibitor, SP-40,40, sulfated glycoprotein 2, testosterone-repressed prostate message 2, apolipoprotein J) / CLU / 14.4
tetraspan 2 / TSPAN-2 / 14.4
kappa-immunoglobulin germline pseudogene / 13.6
troponin C2, fast / TNNC2 / 13.5
cartilage intermediate layer protein, nucleotide pyrophosphohydrolase / CILP / 13.5
immunoglobulin heavy constant mu / IGHM / 12.8
ESTs / 12.6
thrombospondin 4 / THBS4 / 12.3
myocilin, trabecular meshwork inducible glucocorticoid response / MYOC / 11.6
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides / IGJ / 11.1
scavenger receptor class A, member 3 / SCARA3 / 11.0
troponin I, skeletal, fast / TNNI2 / 10.4
polyamine-modulated factor 1 / PMF1 / 9.7
clusterin (complement lysis inhibitor, SP-40,40, sulfated glycoprotein 2, testosterone-repressed prostate message 2, apolipoprotein J) / CLU / 9.7
tenascin XB / TNXB / 9.6
clusterin (complement lysis inhibitor, SP-40,40, sulfated glycoprotein 2, testosterone-repressed prostate message 2, apolipoprotein J) / CLU / 9.4
immunoglobulin heavy constant mu / IGHM / 9.4
nephroblastoma overexpressed gene / NOV / 9.3
sarcomeric muscle protein / SARCOSIN / 8.8
immunoglobulin heavy constant mu / IGHM / 8.8
KIAA1881 protein / KIAA1881 / 8.7
hepatic dihydrodiol dehydrogenase / 8.6
immunoglobulin lambda joining 3 / IGLJ3 / 8.3
chitinase 3-like 2 / CHI3L2 / 8.3
immunoglobulin lambda locus / IGL / 8.2
immunoglobulin heavy constant mu / IGHM / 8.2
phospholipase A2, group IIA (platelets, synovial fluid) / PLA2G2A / 8.0
ESTs / 7.9
fibromodulin / FMOD / 7.8
angiopoietin-like 1 / ANGPTL1 / 7.6
esophageal cancer related gene 4 protein / ECRG4 / 7.5
scrapie responsive protein 1 / SCRG1 / 7.5
actin, alpha 1, skeletal muscle / ACTA1 / 7.4
insulin-like growth factor binding protein 6 / IGFBP6 / 7.0
myosin, heavy polypeptide 2, skeletal muscle, adult / MYH2 / 6.9
ESTs / 6.8
phospholipase A2, group IIA (platelets, synovial fluid) / PLA2G2A / 6.4
tetraspan 2 / TSPAN-2 / 6.4
tenomodulin protein / TNMD / 6.2
WNT1 inducible signaling pathway protein 2 / WISP2 / 6.0
cartilage oligomeric matrix protein (pseudoachondroplasia, epiphyseal dysplasia 1, multiple) / COMP / 6.0
D component of complement (adipsin) / DF / 5.9
ankylosis, progressive homolog (mouse) / ANKH / 5.8
5.8
Ksp37 protein / KSP37 / 5.8
myosin, light polypeptide 1, alkali; skeletal, fast / MYL1 / 5.6
tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) / TNFRSF11B / 5.6
myoglobin / MB / 5.5
WNT inhibitory factor 1 / WIF1 / 5.5
serine (or cysteine) proteinase inhibitor, clade I (neuroserpin), member 1 / SERPINI1 / 5.4
cartilage oligomeric matrix protein (pseudoachondroplasia, epiphyseal dysplasia 1, multiple) / COMP / 5.3
(clone PWHLC2-24) myosin light chain 2 / HUMMLC2B / 5.3
tetranectin (plasminogen binding protein) / TNA / 5.3
sarcomeric muscle protein / SARCOSIN / 5.2
secreted frizzled-related protein 1 / SFRP1 / 5.2
proteoglycan 4, (megakaryocyte stimulating factor, articular superficial zone protein, camptodactyly, arthropathy, coxa vara, pericarditis syndrome) / PRG4 / 5.1
chondroadherin / CHAD / 5.0
tetraspan 2 / TSPAN-2 / 5.0
pim-2 oncogene / PIM2 / 4.9
stathmin-like 2 / STMN2 / 4.9
pro-alpha1 type II collagen / COL2A1 / 4.8
myosin, heavy polypeptide 11, smooth muscle / MYH11 / 4.7
dermatopontin / DPT / 4.6
milk fat globule-EGF factor 8 protein / MFGE8 / 4.6
serum amyloid A1 / SAA1 / 4.5
POU domain, class 2, associating factor 1 / POU2AF1 / 4.5
Homo sapiens cDNA FLJ12924 fis, clone NT2RP2004709, mRNA sequence / 4.5
neurotrophic tyrosine kinase, receptor, type 2 / NTRK2 / 4.5
RAS-like, estrogen-regulated, growth-inhibitor / RERG / 4.4
collagen, type IX, alpha 3 / COL9A3 / 4.4
Immunoglobulin Heavy Chain, Vdjrc Regions / 4.4
deiodinase, iodothyronine, type II / DIO2 / 4.4
G protein-coupled receptor 105 / GPR105 / 4.4
dipeptidylpeptidase IV (CD26, adenosine deaminase complexing protein 2) / DPP4 / 4.3
myosin, heavy polypeptide 7, cardiac muscle, beta / MYH7 / 4.3
ESTs, Highly similar to DKFZP586N2124 protein [Homo sapiens] [H.sapiens] / 4.3
adipose specific 2 / APM2 / 4.3
DKFZP586L2024 protein / NESHBP / 4.2
Homo sapiens cDNA FLJ30555 fis, clone BRAWH2003818, mRNA sequence / 4.2
procollagen C-endopeptidase enhancer 2 / PCOLCE2 / 4.2
hypothetical protein FLJ20152 / FLJ20152 / 4.2
aquaporin 1 (channel-forming integral protein, 28kDa) / AQP1 / 4.1
titin / TTN / 4.1
brain specific protein / CGI-38 / 4.0
alpha-actinin-2-associated LIM protein / ALP / 4.0
nebulin / NEB / 4.0
ESTs, Weakly similar to hypothetical protein FLJ20378 [Homo sapiens] [H.sapiens] / 4.0
carboxypeptidase A3 (mast cell) / CPA3 / 3.9
hypothetical protein BC011859 / LOC113146 / 3.7
ESTs / 3.7
tryptase, alpha / TPS1 / 3.7
troponin T3, skeletal, fast / TNNT3 / 3.6
neurotrophic tyrosine kinase, receptor, type 2 / NTRK2 / 3.6
growth differentiation factor 10 / GDF10 / 3.6
ryanodine receptor 1 (skeletal) / RYR1 / 3.5
chromosome 20 open reading frame 82 / C20orf82 / 3.5
p53-induced protein PIGPC1 / PIGPC1 / 3.5
hypothetical protein MGC24995 / MGC24995 / 3.5
hypothetical protein MGC10848 / MGC10848 / 3.5
basic helix-loop-helix domain containing, class B, 5 / BHLHB5 / 3.5
cysteine-rich protein 1 (intestinal) / CRIP1 / 3.4
ESTs / 3.3
hypothetical protein FLJ20202 / FLJ20202 / 3.3
fibroblast growth factor 9 (glia-activating factor) / FGF9 / 3.3
ESTs, Highly similar to potassium voltage-gated channel, Isk-related subfamily, gene 4; potassium voltage-gated channel-like protein, Isk-related subfamily [Homo sapiens] [H.sapiens] / 3.3
Duffy blood group / FY / 3.2
brother of CDO / BOC / 3.2
collagen, type XIV, alpha 1 (undulin) / COL14A1 / 3.2
Homo sapiens cDNA FLJ40058 fis, clone TCOLN1000180, mRNA sequence / 3.2
KIAA1102 protein / KIAA1102 / 3.2
lipoma HMGIC fusion partner / LHFP / 3.1
ESTs, Weakly similar to cytokine receptor-like factor 2; cytokine receptor CRL2 precusor [Homo sapiens] [H.sapiens] / 3.1
matrix metalloproteinase 13 (collagenase 3) / MMP13 / 3.1
neuroligin / KIAA1260 / 3.1
perilipin / PLIN / 3.0
Ras-related associated with diabetes / RRAD / 3.0
transferrin / TF / 3.0
ESTs, Highly similar to AGRT agrin - rat [R.norvegicus] / 3.0
sorbin and SH3 domain containing 1 / SORBS1 / 3.0
fibulin 1 / FBLN1 / 3.0
Homo sapiens, clone IMAGE:3833472, mRNA, mRNA sequence / 3.0
period homolog 3 (Drosophila) / PER3 / 3.0
ligand of numb-protein X / LNX / 3.0
prostaglandin I2 (prostacyclin) synthase / PTGIS / 2.9
Homo sapiens mRNA; cDNA DKFZp761D1624 (from clone DKFZp761D1624), mRNA sequence / 2.9
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 4 / PLEKHA4 / 2.9
cysteine dioxygenase, type I / CDO1 / 2.9
KIAA1881 protein / KIAA1881 / 2.9
ESTs / 2.9
duodenal cytochrome b / FLJ23462 / 2.9
creatine kinase, brain / CKB / 2.9
retinoic acid receptor responder (tazarotene induced) 1 / RARRES1 / 2.9
hypothetical protein DKFZp451G182 / DKFZp451G182 / 2.8
tetraspan 2 / TSPAN-2 / 2.8
actin binding LIM protein 1 / ABLIM1 / 2.8
complement component 1, s subcomponent / C1S / 2.8
chromosome 1 open reading frame 17 / C1orf17 / 2.8
gelsolin (amyloidosis, Finnish type) / GSN / 2.8
ankylosis, progressive homolog (mouse) / ANKH / 2.8
Homo sapiens, clone IMAGE:3618365, mRNA, mRNA sequence / 2.8
eukaryotic translation elongation factor 1 alpha 2 / EEF1A2 / 2.8
latent transforming growth factor beta binding protein 3 / LTBP3 / 2.8
retinoic acid receptor responder (tazarotene induced) 1 / RARRES1 / 2.8
immunoglobulin heavy constant mu / IGHM / 2.8
ESTs / 2.8
lipoma HMGIC fusion partner / LHFP / 2.7
serine (or cysteine) proteinase inhibitor, clade G (C1 inhibitor), member 1, (angioedema, hereditary) / SERPING1 / 2.7
S100 calcium binding protein A4 (calcium protein, calvasculin, metastasin, murine placental homolog) / S100A4 / 2.7
Homo sapiens mRNA; cDNA DKFZp666J235 (from clone DKFZp666J235), mRNA sequence / 2.7
SNRPN upstream reading frame / SNURF / 2.7
secretory leukocyte protease inhibitor (antileukoproteinase) / SLPI / 2.7
neuronal guanine nucleotide exchange factor / NGEF / 2.7
hypothetical protein FLJ21276 / FLJ21276 / 2.7
insulin-like growth factor 1 (somatomedin C) / IGF1 / 2.7
Homo sapiens cDNA FLJ36544 fis, clone TRACH2006378, mRNA sequence / 2.7
myosin binding protein C, slow type / MYBPC1 / 2.7
apolipoprotein D / APOD / 2.7
sarcolipin / SLN / 2.6
MSTP032 protein / MSTP032 / 2.6
EGF-containing fibulin-like extracellular matrix protein 1 / EFEMP1 / 2.6
proline arginine-rich end leucine-rich repeat protein / PRELP / 2.6
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C / SEMA3C / 2.6
neuronal guanine nucleotide exchange factor / NGEF / 2.6
creatine kinase, brain / CKB / 2.6
four and a half LIM domains 1 / FHL1 / 2.6
cathepsin K (pycnodysostosis) / CTSK / 2.6
ESTs, Weakly similar to hypothetical protein FLJ20837 [Homo sapiens] [H.sapiens] / 2.6
hypothetical protein FLJ21986 / FLJ21986 / 2.6
Microfibril-associated glycoprotein-2 / MAGP2 / 2.6
CD9 antigen (p24) / CD9 / 2.6
retinoic acid receptor responder (tazarotene induced) 1 / RARRES1 / 2.6
nucleolar autoantigen (55kD) similar to rat synaptonemal complex protein / SC65 / 2.6
p53-induced protein PIGPC1 / PIGPC1 / 2.6
H factor 1 (complement) / HF1 / 2.6
hypothetical protein PRO1489 / PRO1489 / 2.6
hypothetical protein FLJ10970 / FLJ10970 / 2.6
2.5
Homo sapiens full length insert cDNA clone YI48C03, mRNA sequence / 2.5
cartilage linking protein 1 / CRTL1 / 2.5
cathepsin K (pycnodysostosis) / CTSK / 2.5
ankyrin 3, node of Ranvier (ankyrin G) / ANK3 / 2.5
microfibrillar-associated protein 4 / MFAP4 / 2.5
KIAA0367 protein / KIAA0367 / 2.5
similar to PH (pleckstrin homology) domain / KIAA2028 / 2.5
matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) / MMP9 / 2.5
LR8 protein / LR8 / 2.5
collagen, type VIII, alpha 2 / COL8A2 / 2.5
aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II) / AKR1C3 / 2.5
transforming growth factor, beta receptor III (betaglycan, 300kDa) / TGFBR3 / 2.5
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C / SEMA3C / 2.4
secretogranin II (chromogranin C) / SCG2 / 2.4
ATP-binding cassette, sub-family A (ABC1), member 8 / ABCA8 / 2.4
ESTs / 2.4
collagen, type VIII, alpha 2 / COL8A2 / 2.4
ectonucleotide pyrophosphatase/phosphodiesterase 1 / ENPP1 / 2.4
CocoaCrisp / LOC83690 / 2.4
Homo sapiens cDNA FLJ12927 fis, clone NT2RP2004743, mRNA sequence / 2.4
nuclear factor I/X (CCAAT-binding transcription factor) / NFIX / 2.4
adenylyl cyclase-associated protein 2 / CAP2 / 2.4
2.4
SPARC-like 1 (mast9, hevin) / SPARCL1 / 2.4
desmuslin / DMN / 2.4
collagen, type VIII, alpha 2 / COL8A2 / 2.4
transforming, acidic coiled-coil containing protein 2 / TACC2 / 2.4
chromosome 1 open reading frame 24 / C1orf24 / 2.3
nucleolar autoantigen (55kD) similar to rat synaptonemal complex protein / SC65 / 2.3
nucleolar autoantigen (55kD) similar to rat synaptonemal complex protein / SC65 / 2.3
human immunodeficiency virus type I enhancer binding protein 2 / HIVEP2 / 2.3
Homo sapiens, clone IMAGE:3833472, mRNA, mRNA sequence / 2.3
Unknown (protein for IMAGE:4183312) [Homo sapiens], mRNA sequence / 2.3
ESTs, Weakly similar to hypothetical protein FLJ20489 [Homo sapiens] [H.sapiens] / 2.3
insulin-like growth factor 1 (somatomedin C) / IGF1 / 2.3
polycystic kidney disease 1 (autosomal dominant) / PKD1 / 2.3
potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3 / KCNS3 / 2.3
endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor, 2 / EDG2 / 2.3
Kruppel-like factor 5 (intestinal) / KLF5 / 2.3
DKFZP586A0522 protein / DKFZP586A0522 / 2.3
tumor endothelial marker 8 / TEM8 / 2.3
angiopoietin-like 2 / ANGPTL2 / 2.3
growth arrest-specific 7 / GAS7 / 2.2
glucocorticoid induced transcript 1 / GLCCI1 / 2.2
peripheral myelin protein 22 / PMP22 / 2.2
ankylosis, progressive homolog (mouse) / ANKH / 2.2
ribonuclease, RNase A family, 1 (pancreatic) / RNASE1 / 2.2
ESTs, Weakly similar to hypothetical protein FLJ20489 [Homo sapiens] [H.sapiens] / 2.2
extracellular matrix protein 2, female organ and adipocyte specific / ECM2 / 2.1
lung type-I cell membrane-associated glycoprotein / T1A-2 / 2.1
solute carrier family 29 (nucleoside transporters), member 1 / SLC29A1 / 2.1
sialyltransferase 1 (beta-galactoside alpha-2,6-sialytransferase) / SIAT1 / 2.1
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 / KCNMA1 / 2.1
FXYD domain containing ion transport regulator 6 / FXYD6 / 2.1
Ras-related associated with diabetes / RRAD / 2.1
neuroblastoma, suppression of tumorigenicity 1 / NBL1 / 2.1
latent transforming growth factor beta binding protein 4 / LTBP4 / 2.1
cartilage linking protein 1 / CRTL1 / 2.1
hypothetical protein DKFZp761F241 / DKFZP761F241 / 2.1
complement component 1, r subcomponent / C1R / 2.1
chromosome 18 open reading frame 1 / C18orf1 / 2.1
cathepsin K (pycnodysostosis) / CTSK / 2.1
CocoaCrisp / LOC83690 / 2.1
ESTs, Weakly similar to hypothetical protein FLJ20958 [Homo sapiens] [H.sapiens] / 2.1
thyrotrophic embryonic factor / TEF / 2.1
dihydropyrimidinase-like 3 / DPYSL3 / 2.0
tumor protein p53 inducible nuclear protein 1 / TP53INP1 / 2.0
thyroid hormone receptor interactor 13 / TRIP13 / -2.0
integrin-binding sialoprotein (bone sialoprotein, bone sialoprotein II) / IBSP / -2.1
jun B proto-oncogene / JUNB / -2.1
suppressor of cytokine signaling 3 / SOCS3 / -2.1
dual specificity phosphatase 6 / DUSP6 / -2.1
cytoskeleton-associated protein 4 / CKAP4 / -2.1
suppressor of cytokine signaling 3 / SOCS3 / -2.2
coactosin-like 1 (Dictyostelium) / COTL1 / -2.2
H2A histone family, member X / H2AFX / -2.2
cyclin A2 / CCNA2 / -2.2
H4 histone family, member G / H4FG / -2.2
karyopherin (importin) beta 2 / KPNB2 / -2.2
angiopoietin 2 / ANGPT2 / -2.2
ESTs, Moderately similar to hypothetical protein FLJ20489 [Homo sapiens] [H.sapiens] / -2.2
proliferating cell nuclear antigen / PCNA / -2.2
thymidylate synthase / -2.3
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 5 (GalNAc-T5) / GALNT5 / -2.3
topoisomerase (DNA) II alpha 170kDa / TOP2A / -2.3
chromosome 20 open reading frame 1 / C20orf1 / -2.3
likely ortholog of mouse Shc SH2-domain binding protein 1 / SHCBP1 / -2.3
eukaryotic translation initiation factor 2, subunit 3 gamma, 52kDa / EIF2S3 / -2.3
lipase A, lysosomal acid, cholesterol esterase (Wolman disease) / LIPA / -2.3
AXIN1 up-regulated 1 / AXUD1 / -2.3
v-jun sarcoma virus 17 oncogene homolog (avian) / JUN / -2.3
endothelial and smooth muscle cell-derived neuropilin-like protein / ESDN / -2.3
nidogen 2 (osteonidogen) / NID2 / -2.3
integrin, beta 2 (antigen CD18 (p95), lymphocyte function-associated antigen 1; macrophage antigen 1 (mac-1) beta subunit) / ITGB2 / -2.3
cytoskeleton associated protein 2 / CKAP2 / -2.3
thymidylate synthetase / TYMS / -2.4
H2A histone family, member Z / H2AFZ / -2.4
v-myc myelocytomatosis viral oncogene homolog (avian) / MYC / -2.4
cathepsin L / CTSL / -2.4
ZW10 interactor / ZWINT / -2.4
a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 1 / ADAMTS1 / -2.4
kinesin family member 14 / KIF14 / -2.4
immediate early response 3 / IER3 / -2.5
Homo sapiens mRNA; cDNA DKFZp313M158 (from clone DKFZp313M158), mRNA sequence / -2.5
collagen, type XI, alpha 1 / COL11A1 / -2.5
KIAA1376 protein / KIAA1376 / -2.5
topoisomerase (DNA) II alpha 170kDa / TOP2A / -2.5
ESTs, Moderately similar to T02670 probable thromboxane A2 receptor isoform beta - human [H.sapiens] / -2.6
HIF-1 responsive RTP801 / RTP801 / -2.6
thymidine kinase 1, soluble / TK1 / -2.6
phosphoserine phosphatase-like / PSPHL / -2.6
hematological and neurological expressed 1 / HN1 / -2.6
nuclear receptor subfamily 4, group A, member 1 / NR4A1 / -2.6
ESTs / -2.6
ubiquitin-conjugating enzyme E2C / UBE2C / -2.6
flap structure-specific endonuclease 1 / FEN1 / -2.6
karyopherin alpha 2 (RAG cohort 1, importin alpha 1) / KPNA2 / -2.6
proteoglycan 1, secretory granule / PRG1 / -2.6
nuclear receptor subfamily 4, group A, member 1 / NR4A1 / -2.6
chemokine (C-C motif) ligand 2 / CCL2 / -2.7
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) / PLA2G7 / -2.7
cysteine-rich, angiogenic inducer, 61 / CYR61 / -2.7
oxidised low density lipoprotein (lectin-like) receptor 1 / OLR1 / -2.7
cell division cycle 2, G1 to S and G2 to M / CDC2 / -2.7
Homo sapiens mRNA; cDNA DKFZp686L1553 (from clone DKFZp686L1553), mRNA sequence / -2.7
gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase) / GGH / -2.8
KIAA1500 protein / KIAA1500 / -2.8
topoisomerase (DNA) II alpha 170kDa / TOP2A / -2.8
cysteine knot superfamily 1, BMP antagonist 1 / CKTSF1B1 / -2.8
ribosomal protein, large P2 / RPLP2 / -2.8
HIF-1 responsive RTP801 / RTP801 / -2.8
integrin, alpha 1 / ITGA1 / -2.8
solute carrier family 2 (facilitated glucose transporter), member 3 / SLC2A3 / -2.9
Homo sapiens mRNA; cDNA DKFZp586O1224 (from clone DKFZp586O1224), mRNA sequence / -2.9
protein regulator of cytokinesis 1 / PRC1 / -2.9
pre-B-cell colony-enhancing factor / PBEF / -2.9
ubiquitin carrier protein / E2-EPF / -2.9
ESTs, Weakly similar to hypothetical protein FLJ20489 [Homo sapiens] [H.sapiens] / -2.9
Fc fragment of IgG, low affinity IIIb, receptor for (CD16) / FCGR3B / -3
integrin, alpha 1 / ITGA1 / -3
highly expressed in cancer, rich in leucine heptad repeats / HEC / -3
ubiquitin-like, containing PHD and RING finger domains, 1 / UHRF1 / -3
chromosome 10 open reading frame 3 / C10orf3 / -3
chemokine (C-X-C motif) receptor 4 / CXCR4 / -3.1
zinc finger protein 331; zinc finger protein 463 / ZNF361 / -3.1
hematological and neurological expressed 1 / HN1 / -3.1
anillin, actin binding protein (scraps homolog, Drosophila) / ANLN / -3.1
antigen identified by monoclonal antibody Ki-67 / MKI67 / -3.1
serine (or cysteine) proteinase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 / SERPINE1 / -3.2
FBJ murine osteosarcoma viral oncogene homolog B / FOSB / -3.2
gap junction protein, alpha 1, 43kDa (connexin 43) / GJA1 / -3.2
thymidine kinase 1, soluble / TK1 / -3.2
BCL2-related protein A1 / BCL2A1 / -3.3
CDC28 protein kinase regulatory subunit 2 / CKS2 / -3.3
HSPC150 protein similar to ubiquitin-conjugating enzyme / HSPC150 / -3.3
serine dehydratase / SDS / -3.3
zinc finger protein 36, C3H type, homolog (mouse) / ZFP36 / -3.4
v-myc myelocytomatosis viral oncogene homolog (avian) / MYC / -3.4
kinesin-like 1 / KNSL1 / -3.4
KIAA0101 gene product / KIAA0101 / -3.4
cyclin B1 / CCNB1 / -3.4
heme oxygenase (decycling) 1 / HMOX1 / -3.5
chemokine (C-X-C motif) ligand 3 / CXCL3 / -3.5
interleukin 1 receptor antagonist / IL1RN / -3.5
Homo sapiens cDNA FLJ38512 fis, clone HCHON2000503, mRNA sequence / -3.6
normal mucosa of esophagus specific 1 / NMES1 / -3.7
vascular endothelial growth factor / VEGF / -3.8
activating transcription factor 3 / ATF3 / -4
cyclin-dependent kinase inhibitor 3 (CDK2-associated dual specificity phosphatase) / CDKN3 / -4
pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) / PPBP / -4
ESTs / -4.1
cyclin B1 / CCNB1 / -4.2
matrix metalloproteinase 12 (macrophage elastase) / MMP12 / -4.3
regulator of G-protein signalling 1 / RGS1 / -4.3
discs, large homolog 7 (Drosophila) / DLG7 / -4.5
Fc fragment of IgG, low affinity IIIa, receptor for (CD16) / FCGR3A / -4.6
melanoma growth stimulatory activity / MGSA / -4.8
lamin B1 / LMNB1 / -4.8
adipose differentiation-related protein / ADFP / -4.8
serine (or cysteine) proteinase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 / SERPINE1 / -4.9
v-fos FBJ murine osteosarcoma viral oncogene homolog / FOS / -4.9
nuclear receptor subfamily 4, group A, member 2 / NR4A2 / -5
MAD2 mitotic arrest deficient-like 1 (yeast) / MAD2L1 / -5
cysteine knot superfamily 1, BMP antagonist 1 / CKTSF1B1 / -5.2
dual specificity phosphatase 1 / DUSP1 / -5.3
interleukin 6 (interferon, beta 2) / IL6 / -6.1
v-fos FBJ murine osteosarcoma viral oncogene homolog / FOS / -6.2
MAD, mothers against decapentaplegic homolog 5 (Drosophila) / MADH5 / -6.3
v-fos FBJ murine osteosarcoma viral oncogene homolog / FOS / -6.8
matrix metalloproteinase 12 (macrophage elastase) / MMP12 / -6.9
nuclear receptor subfamily 4, group A, member 2 / NR4A2 / -7
chemokine (C-X-C motif) ligand 2 / CXCL2 / -7.2
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) / UCHL1 / -10.9
chemokine (C-C motif) ligand 20 / CCL20 / -12
cyclooxygenase-2 / hCox-2 / -13.2
pannexin 3 / PANX3 / -13.5
matrix metalloproteinase 7 (matrilysin, uterine) / MMP7 / -14.1
interleukin 8 / IL8 / -20.3
interleukin 8 / IL8 / -45.3